Sign in
4

Changes in Ownership

Entera Bio Ltd. Filed Acc 0001178913-23-001531

Options or other derivatives

  • Chief Financial Officer acquired 190,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Yaacov-Garbeli Dana · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-24 Grant or award : show line 1 in the form Stock Option (right to buy) +190,000 190,000 D
Loading xslF345X04/zk2329588.xml…